Wordt geladen...
Benzolamide improves oxygenation and reduces acute mountain sickness during a high‐altitude trek and has fewer side effects than acetazolamide at sea level
Acetazolamide is the standard carbonic anhydrase (CA) inhibitor used for acute mountain sickness (AMS), however some of its undesirable effects are related to intracellular penetrance into many tissues, including across the blood–brain barrier. Benzolamide is a much more hydrophilic inhibitor, which...
Bewaard in:
| Gepubliceerd in: | Pharmacol Res Perspect |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4876137/ https://ncbi.nlm.nih.gov/pubmed/27433337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.203 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|